Unlock instant, AI-driven research and patent intelligence for your innovation.

Cell-permeable (ICP)-socs3 recombinant protein and uses thereof

a cell-permeable, recombinant protein technology, applied in the direction of peptide/protein ingredients, osteogenic factors, peptide sources, etc., can solve the problems of poor prognosis of patients with osteogenic disease, limited treatment options, and short life expectancy of patients

Inactive Publication Date: 2017-05-18
CELLIVERY THERAPEUTICS
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent is about creating a better protein called iCP-SOCS3 that can treat solid tumors safely without causing any side-effects. This protein is designed to be cell-permeable, which means it can easily enter cancer cells and start working on them. Overall, this invention provides a promising way to develop new treatments for solid tumors.

Problems solved by technology

However, effective treatment regimens for gastric cancers, especially advanced gastric cancer, are still lacking; therefore, the prognosis of patients with this disease remains poor.
Colorectal cancer is one of the most fatal neoplastic diseases worldwide and a serious global health problem, with over one million new cases and half million mortalities worldwide each year.
Gliomas are the most common type of primary brain tumors are highly malignant and are associated with a very poor prognosis.
Glioblastoma is a very aggressive subtype of glioma with very short life expectancy and limited treatment options.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell-permeable (ICP)-socs3 recombinant protein and uses thereof
  • Cell-permeable (ICP)-socs3 recombinant protein and uses thereof
  • Cell-permeable (ICP)-socs3 recombinant protein and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

nt of Novel Advanced Macromolecule Transduction Domain (aMTD)

[0380]H-regions of signal sequences (HRSP)-derived CPPs (MTS / MTM and MTD) do not have a common sequence, a sequence motif, and / or a common structural homologous feature. In this invention, the aim is to develop improved hydrophobic CPPs formatted in the common sequence and structural motif that satisfy newly determined ‘critical factors’ to have a ‘common function,’ to facilitate protein translocation across the plasma membrane with similar mechanism to the analyzed CPPs.

[0381]The structural motif as follows:

[0382]In Table 9, universal common sequence / structural motif is provided as follows. The amino acid length of the peptides in this invention ranges from 9 to 13 amino acids, mostly 12 amino acids, and their bending potentials are dependent with the presence and location of proline in the middle of sequence (at 5′, 6′, 7′ or 8′ amino acid) and at the end of peptide (at 12′) for recombinant protein bending. Instability ...

example 2

ion of Expression Vectors for Recombinant Proteins Fused to aMTDs

[0383]Our newly developed technology has enabled us to expand the method for making cell-permeable recombinant proteins. The expression vectors were designed for histidine-tagged CRA proteins fused with aMTDs or rPeptides. To construct expression vectors for recombinant proteins, polymerase chain reaction (PCR) had been devised to amplify each designed aMTD or rPeptide fused to CRA.

[0384]The PCR reactions (100 ng genomic DNA, 10 pmol each primer, each 0.2 mM dNTP mixture, 1× reaction buffer and 2.5 U Pfu(+) DNA polymerase (Doctor protein, Korea) was digested on the restriction enzyme site between Nde I (5′) and Sal I (3′) involving 35 cycles of denaturation (95° C.), annealing (62° C.), and extension (72° C.) for 30 seconds each. For the last extension cycle, the PCR reactions remained for 5 minutes at 72° C. Then, they were cloned into the site of pET-28a(+) vectors (Novagen, Darmstadt, Germany). DNA ligation was perf...

example 3

Expression, Purification and Preparation of Recombinant Proteins Fused to aMTDs and rPeptides

[0385]To express recombinant proteins, pET-28a(+) vectors for the expression of CRA proteins fused to a negative control [rPeptide 38 (rP38)], reference hydrophobic CPPs (MTM12 and MTD85) and aMTDs were transformed in E. coli BL21 (DE3) strains. Cells were grown at 37° C. in LB medium containing kanamycin (50 μg / ml) with a vigorous shaking and induced at OD600=0.6 by adding 0.7 mM IPTG (Biopure) for 2 hours at 37° C. Induced recombinant proteins were loaded on 15% SDS-PAGE gel and stained with Coomassie Brilliant Blue (InstantBlue, Expedeon, Novexin, UK) (FIG. 3).

[0386]The E. coli cultures were harvested by centrifugation at 5,000× rpm for 10 minutes, and the supernatant was discarded. The pellet was re-suspended in the lysis buffer (50 mM NaH2PO4, 10 mM Imidazol, 300 mM NaCl, pH 8.0). The cell lysates were sonicated on ice using a sonicator (Sonics and Materials, Inc., Newtown, Conn., USA) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
tissue permeabilityaaaaaaaaaa
aliphatic indexaaaaaaaaaa
affinityaaaaaaaaaa
Login to View More

Abstract

The present invention relates to providing improved cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof. Preferably, the iCP-SOCS3 recombinant protein may be used as protein-based anti-solid tumor agent by utilizing the platform technology for macromolecule intracellular transduction.

Description

TECHNICAL FIELD[0001]The present invention relates to providing improved cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof. Preferably, the iCP-SOCS3 recombinant protein may be used as protein-based anti-solid tumor agent by utilizing the platform technology for macromolecule intracellular transduction.BACKGROUND ART[0002]The Janus kinase signal transducers and activators of transcription signaling (JAK / STAT) plays important roles in immune responses, including oncogenesis. So many investigations demonstrated that STAT-3, an important member of STAT proteins, was considered as a proto-oncogene in various types of disorder. STAT-3 is phosphorylated and dimerizes by the Janus kinase (JAK), and its overexpression and constitutive activation can significantly induce cell proliferation, tumor angiogenesis, invasion. Meanwhile, inhibition of JAK-STAT signaling led to suppress the cancer cell growth and induce apoptosis. Suppressor of cytokine signaling-3 (SOCS3), a kind of e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/47C07K7/08
CPCC07K14/4703C07K7/08A61K38/00C07K2319/40C07K2319/10C07K14/51C07K2319/21A61K38/08A61K38/10A61K38/1709A61K38/1761C07K7/06C07K14/4702C07K2319/01C07K2319/00C07K14/47
Inventor JO, DAEWOONGCHOI, YOUNGSILLEE, KUYSOOKSHIN, SEULMEEKIM, JIHYEKIM, JEONGMINKIM, CHOHYUN
Owner CELLIVERY THERAPEUTICS